These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 30371118)

  • 1. Validation of a clinical decision tree to predict if a patient has a bacteraemia due to a β-lactamase producing organism.
    Sousa A; Pérez-Rodríguez MT; Suarez M; Val N; Martínez-Lamas L; Nodar A; Crespo M
    Infect Dis (Lond); 2019 Jan; 51(1):32-37. PubMed ID: 30371118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Clinical Decision Tree to Predict Whether a Bacteremic Patient Is Infected With an Extended-Spectrum β-Lactamase-Producing Organism.
    Goodman KE; Lessler J; Cosgrove SE; Harris AD; Lautenbach E; Han JH; Milstone AM; Massey CJ; Tamma PD;
    Clin Infect Dis; 2016 Oct; 63(7):896-903. PubMed ID: 27358356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. β LACTA test performance for detection of extended-spectrum β-lactamase-producing Gram-negative bacilli directly on bronchial aspirates samples: a validation study.
    Gallah S; Benzerara Y; Tankovic J; Woerther PL; Bensekri H; Mainardi JL; Arlet G; Vimont S; Garnier M
    Clin Microbiol Infect; 2018 Apr; 24(4):402-408. PubMed ID: 28782646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and antibacterial resistance patterns of extended-spectrum beta-lactamase producing Gram-negative bacteria isolated from ocular infections.
    Rameshkumar G; Ramakrishnan R; Shivkumar C; Meenakshi R; Anitha V; Venugopal Reddy YC; Maneksha V
    Indian J Ophthalmol; 2016 Apr; 64(4):303-11. PubMed ID: 27221683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Trends in the prevalence of extended-spectrum beta-lactamase-producing gram-negative bacilli in a teaching hospital in Madrid, Spain].
    González-Vélez AE; Díaz-Agero Pérez C; Robustillo-Rodela A; Pita-López MJ; Cornejo-Gutiérrez AM; Pedrero-Pérez P; Monge-Jodra V
    Med Clin (Barc); 2013 Jul; 141(1):8-12. PubMed ID: 22982130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extended-spectrum β-lactamase-producing bacteria caused less than 5% of urinary tract infections in a paediatric emergency centre.
    Jacmel L; Timsit S; Ferroni A; Auregan C; Angoulvant F; Chéron G
    Acta Paediatr; 2017 Jan; 106(1):142-147. PubMed ID: 27542840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ertapenem for the treatment of extended-spectrum beta-lactamase-producing Gram-negative bacterial infections.
    Teng CP; Chen HH; Chan J; Lye DC
    Int J Antimicrob Agents; 2007 Oct; 30(4):356-9. PubMed ID: 17631986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A methodological comparison of risk scores versus decision trees for predicting drug-resistant infections: A case study using extended-spectrum beta-lactamase (ESBL) bacteremia.
    Goodman KE; Lessler J; Harris AD; Milstone AM; Tamma PD
    Infect Control Hosp Epidemiol; 2019 Apr; 40(4):400-407. PubMed ID: 30827286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and Molecular Characteristics of Neonatal Extended-Spectrum β-Lactamase-Producing Gram-Negative Bacteremia: A 12-Year Case-Control-Control Study of a Referral Center in Taiwan.
    Tsai MH; Lee IT; Chu SM; Lien R; Huang HR; Chiang MC; Fu RH; Hsu JF; Huang YC
    PLoS One; 2016; 11(8):e0159744. PubMed ID: 27505270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of extended spectrum beta-lactamase among multidrug resistant gram-negative isolates from a general hospital in Saudi Arabia.
    Kader AA; Kumar AK
    Saudi Med J; 2004 May; 25(5):570-4. PubMed ID: 15138522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. β LACTA testing may not improve treatment decisions made with MALDI-TOF MS-informed antimicrobial stewardship advice for patients with Gram-negative bacteraemia: a prospective comparative study.
    Dépret F; Aubry A; Fournier A; Charles-Nelson A; Katsahian S; Compain F; Mainardi JL; Fernandez-Gerlinger MP
    J Med Microbiol; 2018 Feb; 67(2):183-189. PubMed ID: 29265997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacteraemia in adults due to glucose non-fermentative Gram-negative bacilli other than P. aeruginosa.
    Vidal F; Mensa J; Almela M; Olona M; Martínez JA; Marco F; López MJ; Soriano A; Horcajada JP; Gatell JM; Richart C
    QJM; 2003 Mar; 96(3):227-34. PubMed ID: 12615987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of multidrug-resistant gram-negative bacilli producing extended-spectrum β-lactamases (ESBLs) and ESBL genes in solid organ transplant recipients.
    Men TY; Wang JN; Li H; Gu Y; Xing TH; Peng ZH; Zhong L
    Transpl Infect Dis; 2013 Feb; 15(1):14-21. PubMed ID: 23013385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors, outcome and impact of empirical antimicrobial treatment in extended-spectrum β-lactamase-producing Escherichia coli bacteraemia.
    Van Aken S; Lund N; Ahl J; Odenholt I; Tham J
    Scand J Infect Dis; 2014 Nov; 46(11):753-62. PubMed ID: 25195648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of acquiring multidrug-resistant Gram-negative bacilli from prior room occupants in the intensive care unit.
    Nseir S; Blazejewski C; Lubret R; Wallet F; Courcol R; Durocher A
    Clin Microbiol Infect; 2011 Aug; 17(8):1201-8. PubMed ID: 21054665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid detection of ESBL-producing gram-negative bacteria isolated from blood: a reasonable and reliable tool for middle and low resource countries.
    Cuellar-Rodríguez JM; Ponce-De-León A; Quiroz-Mejía R; Galindo-Fraga A; Rolón-Montes-de-Oca AL; Hernández-Durán M; Ruiz-Palacios GM; Sifuentes-Osornio J
    Rev Invest Clin; 2009; 61(4):306-12. PubMed ID: 19848308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular and clinical characterization of plasmid-mediated AmpC β-lactamase-producing Escherichia coli bacteraemia: a comparison with extended-spectrum β-lactamase-producing and non-resistant E. coli bacteraemia.
    Matsumura Y; Nagao M; Iguchi M; Yagi T; Komori T; Fujita N; Yamamoto M; Matsushima A; Takakura S; Ichiyama S
    Clin Microbiol Infect; 2013 Feb; 19(2):161-8. PubMed ID: 22332968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of extended spectrum beta lactamase (ESBL) production in gram negative isolates from pyogenic infection in tertiary care hospital of eastern Nepal.
    Shrestha S; Amatya R; Dutta R
    Nepal Med Coll J; 2011 Sep; 13(3):186-9. PubMed ID: 22808812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and microbiological implications of time-to-positivity of blood cultures in patients with Gram-negative bacilli bacteremia.
    Palmer HR; Palavecino EL; Johnson JW; Ohl CA; Williamson JC
    Eur J Clin Microbiol Infect Dis; 2013 Jul; 32(7):955-9. PubMed ID: 23397233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of prior cultures in predicting antibiotic resistance of bloodstream infections due to Gram-negative pathogens: a multicentre observational cohort study.
    MacFadden DR; Coburn B; Shah N; Robicsek A; Savage R; Elligsen M; Daneman N
    Clin Microbiol Infect; 2018 May; 24(5):493-499. PubMed ID: 28811241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.